Skip to main content

Table 4 Median regression analysis of total cost

From: Type 2 diabetes mellitus in Bangladesh: a prevalence based cost-of-illness study

Variables Unadjusted Adjusted
Coefficients p-value 95% confidence interval (CI) Coefficients p-value 95% confidence interval (CI)
Gender (ref: Male)
 Female 19.03 0.492 −35.32-73.37 44.85 0.036 3.02–86.68
Age (≤40 years)
 41–60 years 82.85 0.107 −17.79-183.49 21.13 0.419 −30.13-72.39
 61–80 years 221.91 < 0.001 113.60–330.24 2.86 0.930 −60.70-66.41
  ≥ 80 years 741.58 < 0.001 499.87–938.30 170.76 0.708 − 723.11-1064.64
Mode of treatment (ref: OHA)
 Insulin 140.69 0.042 5.28–276.09 65.40 0.260 −48.28-179.07
 Insulin + OHA 307.38 < 0.001 237.90–377.65 152.87 < 0.001 107.45–198.30
Duration of diabetes (ref: ≤5 year)
 6–10 78.36 0.080 −9.42-166.15 17.59 0.403 −23.68-58.82
  ≥ 11 368.68 < 0.001 289.32–448.04 66.93 0.025 8.55–125.32
HbA1c (ref: ≤6.9)
 Fair (7–7.9) 45.42 0.216 −26.60-177.43 −1.20 0.949 −63.50-59.51
 Poor (≥8) 79.41 0.009 20.30–138.53 22.50 0.406 −30.58-75.58
History of co-morbidity (ref: None)
 Hypertension 164.89 < 0.001 76.10–252.79 30.13 0.213 −17.25-77.51
 Dyslipidaemia −42.17 0.494 − 163.00-78.66 2.88 0.924 −65.16-61.91
 Hypertension+dyslipidaemia 169.07 0.001 68.60–269.55 53.07 0.098 −9.75-115.89
Number of complication (ref: None)
 One or two 210.54 < 0.001 134.48–28,660 63.69 0.003 21.70–105.68
 Three or more 847.72 < 0.001 739.82–955.63 440.93 < 0.001 274.08–607.85